Paris Christodoulou | Metabolomics | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

           Researcher Information
Researcher Paris Christodoulou
Affiliation University of West Attica
Country Greece
Scopus ID 57203751539
Documents 26
Citations 409
h-index 9
Subject Area Metabolomics
Event International Molecular Biologist Awards
ORCID 0000-0002-3975-0832
Google Scholar 3Lrfe3cAAAAJ

Paris Christodoulou

University of West Attica, Greece

Paris Christodoulou is affiliated with the University of West Attica in Greece and has an indexed research profile in the field of Metabolomics. The available bibliometric information records 26 documents, 409 citations, and an h-index of 9, providing quantitative indicators of research productivity and scholarly visibility.  The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, methodological development, and contributions that advance knowledge within their field.[1][2]

Abstract

Paris Christodoulou’s academic profile is associated with research in metabolomics, a multidisciplinary field concerned with the systematic study of small-molecule metabolites and their relationships with biological processes. His scholarly record includes 26 documents and 409 citations, with an h-index of 9 according to the supplied Scopus information. These indicators provide a quantitative representation of publication activity and citation influence and may be considered alongside qualitative assessments of originality, scientific methodology, and research significance.[1][3]

Keywords

Paris Christodoulou, Innovative Research Award, University of West Attica, Greece, Metabolomics, Metabolite Analysis, Systems Biology, Biomedical Research, Scientific Innovation, Research Impact.

Introduction

Metabolomics is an analytical research discipline that examines the collection of metabolites present in biological systems. It has applications across biomedical research, systems biology, nutrition, pharmacology, environmental science, and related areas. Modern metabolomics commonly integrates analytical technologies with computational and statistical approaches to characterize metabolic variation and identify biologically relevant patterns.[4]

Research recognition in this area may incorporate several dimensions, including the number and quality of scholarly publications, citation activity, methodological innovation, interdisciplinary collaboration, and the broader relevance of research findings. Bibliometric measures such as the h-index are useful quantitative indicators but are generally interpreted in conjunction with disciplinary and qualitative considerations.[3][5]

Research Profile

Paris Christodoulou is affiliated with the University of West Attica in Greece. The supplied scholarly profile identifies Metabolomics as the principal subject area and records an indexed research output of 26 documents, 409 citations, and an h-index of 9. The profile is also associated with an ORCID identifier, providing a persistent digital identifier for distinguishing the researcher within scholarly communication systems.[1][2]

  • Affiliation: University of West Attica, Greece.
  • Primary subject area: Metabolomics.
  • Scopus Author ID: 57203751539.
  • Indexed documents: 26.
  • Recorded citations: 409.
  • h-index: 9.

Research Contributions

Research in metabolomics contributes to understanding biological systems by examining changes in metabolite concentrations and interactions. The field combines experimental measurements with analytical and computational methods to interpret complex biochemical datasets. Such approaches can support biomarker research, pathway analysis, disease investigation, nutritional studies, and other applications in life and health sciences.[4]

Within this broader scientific context, an innovative research profile may be evaluated through the development or application of analytical strategies, the generation of reproducible datasets, interdisciplinary collaboration, and the translation of findings into new scientific knowledge. The available publication and citation indicators associated with Christodoulou provide measurable evidence of scholarly activity, while detailed evaluation of individual contributions should be based on the underlying publications and their scientific content.[1][5]

Publications

The supplied Scopus profile records 26 indexed documents for Paris Christodoulou. Publication records in an indexed database can provide evidence of research continuity, collaboration, and dissemination, although the scientific significance of individual publications is best assessed through article-level examination, journal context, methodological rigor, and subsequent scholarly use.[1]

  • 26 documents reported in the supplied Scopus author profile.
  • Research activity associated with the field of Metabolomics.
  • Scholarly publications contributing to the indexed research record.

Research Impact

The reported citation count of 409 indicates that the research record has received measurable attention within the scholarly literature. The h-index of 9 further summarizes a combination of publication output and citation distribution, although the interpretation of h-index values varies among disciplines, career stages, publication practices, and database coverage.[3][5]

Citation-based indicators should therefore be considered complementary rather than definitive measures of research quality. For an award assessment, publication quality, originality, methodological contribution, reproducibility, collaboration, and influence on subsequent research can provide additional dimensions for evaluating scientific impact.[5]

Award Suitability

The available academic indicators provide a documented basis for considering Paris Christodoulou for an Innovative Research Award. The combination of an indexed publication record, 409 citations, an h-index of 9, and specialization in metabolomics represents a measurable research profile. Final award suitability should, however, incorporate independent review of the candidate’s publications, originality, scientific significance, and contribution to the field in accordance with the criteria established by the awarding organization.[1][5]

Conclusion

Paris Christodoulou’s research profile is associated with the University of West Attica and the scientific field of metabolomics. The supplied bibliometric information records 26 documents, 409 citations, and an h-index of 9. These indicators establish a measurable record of scholarly productivity and visibility. In the context of an Innovative Research Award, they can serve as supporting evidence alongside a detailed qualitative assessment of research originality, methodological contribution, and scientific impact.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Paris Christodoulou, Author ID 57203751539. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57203751539
  2. ORCID. (n.d.). Paris Christodoulou — ORCID record 0000-0002-3975-0832. ORCID.
    https://orcid.org/0000-0002-3975-0832
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  4. Patti, G. J., Yanes, O., & Siuzdak, G. (2012). Innovation: Metabolomics: the apogee of the omics trilogy. Nature Reviews Molecular Cell Biology, 13, 263–269.
    https://doi.org/10.1038/nrm3314
  5. Google Scholar. (n.d.). Paris Christodoulou — Google Scholar profile.
    https://scholar.google.com/citations?user=3Lrfe3cAAAAJ&hl=el

MAYUR DOKE | Systems Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. MAYUR DOKE | Systems Biology | Best Researcher Award

Post doctoral scientists, at University of Miami, United States. 

Dr. Mayur A. Doke is an accomplished molecular biologist specializing in pancreatic plasticity and exocrine-endocrine interactions. His research leverages advanced bioinformatics and single-cell RNA sequencing to investigate tissue dynamics. With a strong foundation in molecular biology, he is recognized for his contributions to understanding complex biological processes through innovative techniques such as RNA-Seq, methylation sequencing, and calcium signaling. Dr. Doke has an impressive track record with 16 peer-reviewed publications, demonstrating his expertise in molecular biology and bioinformatics.

Profile

Scopus

Google Scholar

ORCID

Education

Dr. Doke holds a PhD in Cancer Biology from Florida International University (2013-2018), where he focused on the role of ID3 and endocrine-disrupting chemicals in proliferative vascular lesions leading to diseases such as pulmonary artery hypertension and non-small cell lung cancer. He earned his Master’s (M.Sc.) and Bachelor’s (B.Sc.) degrees in Environmental Science and Biotechnology, respectively, from Mumbai University.

Experience

Dr. Doke is currently a Postdoctoral Researcher at the Diabetes Research Institute, University of Miami, where he employs cutting-edge techniques such as single-cell RNA sequencing and pancreatic slice cultures. His prior experience includes positions at Texas A&M University and the Icahn School of Medicine at Mount Sinai, where he worked on modeling HIV neuropathology, epigenetic signatures, and RNA sequencing. His diverse skill set spans molecular biology, bioinformatics, and high-performance computing, making him a versatile researcher in his field.

Research Interests

Dr. Doke’s research interests lie in understanding the molecular underpinnings of tissue plasticity, particularly in pancreatic and brain tissues. His expertise encompasses bioinformatics, scRNA-seq analysis, epigenetics, and metabolomics, with a focus on the effects of environmental disruptors and diseases like HIV on cellular functions. He is particularly interested in the intersection of molecular biology and computational biology to uncover new insights into human disease mechanisms.

Awards

Throughout his academic journey, Dr. Doke has been recognized for his scientific contributions, receiving accolades for his research and presentations at national and international platforms. His dedication to advancing the fields of molecular biology and bioinformatics has earned him recognition from his peers and institutions alike.

Publications

Dr. Doke has published extensively in prestigious journals. His work includes:

  • Doke, M., et al. (2023). Dynamic scRNA-seq of live human pancreatic slices reveals functional endocrine cell neogenesis through an intermediate ducto-acinar stage.
    Journal: Cell Metabolism
    DOI: Not provided (please provide the exact DOI to retrieve more specific details).
    Summary: This study employs single-cell RNA sequencing (scRNA-seq) on live human pancreatic slices to uncover the process of endocrine cell neogenesis. It identifies an intermediate stage involving ducto-acinar cells, suggesting a new pathway for the formation of functional endocrine cells, which may be crucial for understanding pancreatic regeneration and diabetes.
  • Doke, M., et al. (2023). Genomic Alterations and Aberrant Molecular Pathways in Arrhythmogenic Cardiomyopathy.
    Journal: The American Journal of Cardiology
    DOI: Not provided (please provide the exact DOI for more details).
    Summary: This research explores the genetic mutations and disrupted molecular pathways that contribute to arrhythmogenic cardiomyopathy (ACM). It highlights specific genomic alterations and offers insight into the disease’s pathology, providing potential targets for therapeutic interventions.
  • Avecilla, V., Doke, M., et al. (2017). Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease.
    Journal: BioMed Research International
    DOI: Not provided (please provide the exact DOI for additional information).
    Summary: This paper investigates the role of the Inhibitor of DNA Binding/Differentiation-3 (ID3) protein and endocrine-disrupting chemicals (EDCs) in the development of chronic diseases. It suggests that ID3 and EDCs may influence gene expression and contribute to the onset of conditions such as cancer, diabetes, and cardiovascular diseases.
  • Doke, M., et al. (2020). HIV-1 Tat and cocaine impact mitochondrial epigenetics: effects on DNA methylation.
    Journal: Epigenetics
    DOI: Not provided (please provide the exact DOI for specifics).
    Summary: This study examines the combined effects of the HIV-1 Tat protein and cocaine on mitochondrial epigenetics. The findings reveal that both factors alter DNA methylation patterns, particularly in genes related to mitochondrial function, providing insights into how HIV and substance abuse may contribute to cellular damage and disease progression.

Conclusion

Dr. Mayur A. Doke’s extensive expertise in molecular biology, bioinformatics, and innovative research techniques, along with his significant publication record, makes him a highly suitable candidate for the Best Researcher Award. His ability to contribute to both foundational and applied research in areas like pancreatic biology and HIV neuropathology highlights his versatility and commitment to advancing science. Expanding his leadership in independent research projects and securing additional funding would further solidify his position as a top researcher in the scientific community.